AlphaCentric Advisors
AlphaCentric Advisors reported 245 stocks worth $113M in its 13F filing for Q3 2026, filed Nov 3, 2026. Its largest holdings are SHY (4.8%), GILD (2.8%) and IWD (2.6%). Compared with Q2 2026, the fund opened new positions in PINE, IYR and ASML, added to SHY, GILD and IWD, trimmed UMAC, PSNL and BFS and sold out of QQQ, QQQM and HHH.
Latest filing: what AlphaCentric Advisors did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 5 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() SHY Ishares 1-3 Year Treasry | $5.4M | 4.8% | 66K | +53K (+410%) | 5 of 5 | |
| 2 | ![]() GILD Gilead Sciences Inc | $3.2M | 2.8% | 21K | +852 (+4%) | 5 of 5 | |
| 3 | ![]() IWD Ishares TR | $3M | 2.6% | 12K | +6,249 (+108%) | 5 of 5 | |
| 4 | ![]() RPV Invesco Exchange Traded FD T | $2.9M | 2.6% | 25K | +13K (+110%) | 5 of 5 | |
| 5 | ![]() VRTX Vertex Pharmaceuticals I | $2.7M | 2.4% | 5,115 | +113 (+2%) | 5 of 5 | |
| 6 | ![]() INVH Invitation Homes Inc | $1.9M | 1.7% | 73K | No change | 4 of 5 | |
| 7 | ![]() AZN Astrazeneca PLC Ord | $1.9M | 1.7% | 12K | +472 (+4%) | 3 of 5 | |
| 8 | ![]() ROIV Roivant Sciences Ltd | $1.8M | 1.6% | 51K | +2,180 (+5%) | 4 of 5 | |
| 9 | ![]() INCY Incyte Corp | $1.8M | 1.6% | 15K | +689 (+5%) | 4 of 5 | |
| 10 | ![]() ARGX Argenx SE | $1.8M | 1.6% | 1,841 | +35 (+2%) | 4 of 5 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
APOGEE THERAPEUTICS INC | $1.5M | 12K |
![]() QQQ Invesco Qqq TR | $1.4M | 1,860 |
![]() QQQM Invesco Nasdaq | $1.4M | 4,518 |
![]() HHH Howard Hughes Holdings Inc | $1.1M | 15K |
![]() SMA Smartstop Self Storag REIT I | $813K | 25K |
🔒 Free account: see all 30.
Reported value
last 5 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 3, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →AlphaCentric Advisors 13F FAQ
What does AlphaCentric Advisors own?
AlphaCentric Advisors reported 245 stocks worth $113M in its 13F filing for Q3 2026, filed Nov 3, 2026. Its largest holdings are SHY (4.8%), GILD (2.8%) and IWD (2.6%). The table above lists every position in the filing (the top 10 without an account).
What did AlphaCentric Advisors buy and sell in Q3 2026?
Compared with Q2 2026: 34 new positions, 147 added to, 40 trimmed and 48 sold out. New positions include PINE, IYR and ASML. It sold all of QQQ, QQQM and HHH.
When will AlphaCentric Advisors file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is AlphaCentric Advisors's portfolio worth?
The Q3 2026 filing reports $113M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.

























